Browse by Departments, Units and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | Creators | No Grouping
2012 | 2011 | 2010 | 2009 | 2008 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
Number of items at this level: 84.


Tian, B., Al-Jamal, W.T., Bossche, J. van den and Kostarelos, K. (2012) Design and Engineering of Multifunctional Quantum Dot-Based Nanoparticles for Simultaneous Therapeutic-Diagnostic Applications. Multifunctional Nanoparticles for Drug Delivery Applications (4). pp. 345-365. 10.1007/978-1-4614-2305-8_16.

Lacerda, L., Russier, J., Pastorin, G., Herrero, M.A., Venturelli, E., Dumortier, H., Al-Jamal, K.T., Prato, M., Kostarelos, K. and Bianco, A. (2012) Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials, 33 (11). pp. 3334-3343. 10.1016/j.biomaterials.2012.01.024.

Liu, Y., Servant, A., Guy, O.J., Al-Jamal, K.T., Williams, P.R., Hawkins, K.M. and Kostarelos, K. (2012) An electric-field responsive microsystem for controllable miniaturised drug delivery applications. Sensors and Actuators B: Chemical . 10.1016/j.snb.2011.12.069. (In Press)


Raffa, V., Gherardini, L., Vittorio, O., Bardi, G., Ziaei, A., Pizzorusso, T., Riggio, C., Nitodas, S.F., Karachalios, T.K., Al-Jamal, K.T., Kostarelos, K., Costa, M. and Cuschieri, A. (2011) Carbon nanotube-mediated wireless cell permeabilization: drug and gene uptake. Nanomedicine, 6 (10). pp. 1709-1718. 10.2217/nnm.11.62.

Osman, R., Kan, P.L., Awad, G., Mortada, N., EL-Shamy, A-E. and Alpar, H.O. (2011) Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination. International Journal of Pharmaceutics, 408 (1-2). pp. 257-265. 10.1016/j.ijpharm.2011.02.013.

Van den Bossche, J., Al-Jamal, W.T., Yilmazer, A., Bizzarri, E., Tian, B. and Kostarelos, K. (2011) Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. Biomaterials, 32 (11). pp. 3085-3093. 10.1016/j.biomaterials.2010.12.043.

Tian, B., Al-Jamal, W.T., Al-Jamal, K.T. and Kostarelos, K. (2011) Doxorubicin-loaded lipid-quantum dot hybrids: Surface topography and release properties. International Journal of Pharmaceutics, 416, (2). pp. 443-447. 10.1016/j.ijpharm.2011.01.057 .


Al-Jamal, K.T. and Kostarelos, K. (2010) Assessment of Cellular Uptake and Cytotoxicity of Carbon Nanotubes Using Flow Cytometry. Methods in Molecular Biology (Clifton, N.J.), 625 (3). pp. 123-134. 10.1007/978-1-60761-579-8_11.

Wang, Y., Lam, J., Zhang, B., Tomlins, P.E., Li, X., Alpar, H.O., Wertheim, D.F., Jones, A.S. and Coombes, A.G.A. (2010) Biomechanical Characterization of a Micro/Macroporous Polycaprolactone Tissue Integrating Vascular Graft. Cardiovascular Engineering and Technology, 1 (3). pp. 202-215. doi:10.1007/s13239-010-0019-1.

Kostarelos, K., Bianco, A. and Prato, M. (2010) Complement monitoring of carbon nanotubes. Nature Nanotechnology, 5 (6). pp. 382-383. 10.1038/nnano.2010.110.

Bossche, J. van den, Al-Jamal, W.T., Tian, B., Nunes, A., Fabbro, C., Bianco, A., Prato, M. and Kostarelos, K. (2010) Efficient receptor-independent intracellular translocation of aptamers mediated by conjugation to carbon nanotubes. Chemical Communications, 46 (39). pp. 7379-7381. 10.1039/c0cc02092c.

Nunes, A., Amsharov, N., Guo, C., Van den Bossche, J., Santhosh, P., Karachalios, T.K., Nitodas, S.F., Burghard, M., Kostarelos, K. and Al-Jamal, K.T. (2010) Hybrid Polymer-Grafted Multiwalled Carbon Nanotubes for In vitro Gene Delivery. Small, 6 (20). pp. 2281-2291. 10.1002/smll.201000864.

Li, M., Al-Jamal, K.T., Kostarelos, K. and Reineke, J. (2010) Physiologically Based Pharmacokinetic Modeling of Nanoparticles. ACS Nano, 4 (11). pp. 6303-6317. 10.1021/nn1018818.

Meynard-Moyon, C., Kostarelos, K., Prato, M. and Bianco, A. (2010) Functionalized carbon nanotubes for probing and modulating molecular functions. Chemistry and Biology, 17 (2). pp. 107-115. 10.1016/j.chembiol.2010.01.009.

Vigor, K.L., Kyrtatos, P.G., Minogue, S., Al-Jamal, K.T., Kogelberg, H., Tolner, B., Kostarelos, K., Begent, R.H., Pankhurst, Q.A., Lythgoe, M.F. and Chester, K.A. (2010) Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials, 31 (6). pp. 1307-1315. 10.1016/j.biomaterials.2009.10.036 .

Samori, C., Ali-Boucetta, H., Sainz, R., Guo, C., Toma, F.M., Fabbro, C., Da Ros, T., Prato, M., Kostarelos, K. and Bianco, A. (2010) Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers. Chemical Communications, 46 (9). pp. 1494-1496. 10.1039/b923560d.

Kostarelos, K. (2010) Nanorobots for medicine: how close are we? Nanomedicine, 5 (3). pp. 341-342. 10.2217/nnm.10.19 .

Florindo, H., Pandit, S., Goncalves, I., Alpar, H.O. and Almeida, A.J. (2010) Surface modified polymeric nanoparticles for immunisation against equine strangles. International Journal of Pharmaceutics, 390 (1). pp. 25-31. 10.1016/j.ijpharm.2009.10.009 .

Kyriakou, I., Celedon, C., Segura, R., Emfietzoglou, D., Vargas, P., Valdes, J.E., Abril, I., Denton, C.D., Kostarelos, K. and Garcia-Molina, R. (2010) Energy loss of protons in carbon nanotubes: experiments and calculations. Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms, 268 (11-12). pp. 1781-1785. 10.1016/j.nimb.2010.02.073 .

Hong, S.Y., Tobias, G., Al-Jamal, K.T., Ballesteros, B., Ali-Boucetta, H., Lozana-Perez, S., Nellist, P.D., Sim, R.B., Finucane, C., Mather, S.J., Green, M.L., Kostarelos, K. and Davis, B.G. (2010) Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nature Materials, 9 (6). pp. 485-490. 10.1038/nmat2766.

Meynard-Moyon, C., Venturelli, E., Fabbro, C., Samori, C., Da Ros, T., Kostarelos, K., Prato, M. and Bianco, A. (2010) The alluring potential of functionalized carbon nanotubes in drug discovery. Expert Opinion on Drug Discovery, 5 (7). pp. 691-707. 10.1517/17460441.2010.490552.


Wang, Y., Chang, H-I., Li, X., Alpar, H.O. and Coombes, A. (2009) Delivery of bioactive macromolecules from microporous polymer matrices: release and activity profiles of lysozyme, collagenase and catalase. European Journal of Pharmaceutical Sciences, 37 . pp. 387-394. 10.1016/j.ejps.2009.03.010.

Kaye, R.S., Purewal, T.S. and Alpar, H.O. (2009) Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. Journal of Pharmaceutical Sciences, 98 (11). pp. 4055-4068. 10.1002/jps.21673.

Jorgensen, M.R., Bhurruth-Alcor, Y., Rost, T., Bohov, P., Muller, M., Guisado, C., Kostarelos, K., Dyroy, E., Berge, R.K., Miller, A.D. and Skorve, J. (2009) Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome. Journal of Medicinal Chemistry, 52 (4). pp. 1172-1179. 10.1021/jm801019s.

Al-Jamal, W.T., Al-Jamal, K.T., Tian, B., Cakebread, A., Halket, J.M. and Kostarelos, K. (2009) Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration. Molecular Pharmaceutics, 6 (2). pp. 520-530. 10.1021/mp800187d.

Singh, R. and Kostarelos, K. (2009) Designer adenoviruses for nanomedicine and nanodiagnostics. Trends in Biotechnology, 27 (4). pp. 220-229. 10.1016/j.tibtech.2009.01.003.

Uchida, M., Li, X., Mertens, P. and Alpar, H.O. (2009) Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun. Biochimica et Biophysica Acta, 1790 (8). pp. 754-764. 10.1016/j.bbagen.2009.05.013.


Singh, R., Tian, B. and Kostarelos, K. (2008) Artificial envelopment of non-enveloped viruses: enhancing adenovirus tumor targeting in vivo. FASEB Journal, 22 (9). pp. 3389-3402. 10.1096/fj.08-103275.

Lacerda, L., Bianco, A., Prato, M. and Kostarelos, K. (2008) Carbon nanotube cell translocation and delivery of nucleic acids in vitro and in vivo. Journal of Materials Chemistry, 18 (1). pp. 17-22. 10.1039/b710800a.

Lacerda, L., Herrero, M.A., Venner, K., Bianco, A., Prato, M. and Kostarelos, K. (2008) Carbon nanotube shape and individualization critical for renal excretion. Small, 4 (8). pp. 1130-1132. 10.1002/smll.200800323.

Prato, M., Kostarelos, K. and Bianco, A. (2008) Functionalized carbon nanotubes in drug design and discovery. Accounts of Chemical Research, 41 (1). pp. 60-68. 10.1021/ar700086b.

Al-Jamal, W.T., Al-Jamal, K.T., Bomans, P.H., Frederik, P.M. and Kostarelos, K. (2008) Functionalized quantum dot-liposome hybrids as muti-modal nanoparticles for cancer. Small, 4 (9). pp. 1406-1415. 10.1002/smll.200701043.

Kostarelos, K., Bianco, A. and Prato, M. (2008) Hype around nanotubes creates unrealistic hopes. Nature, 453 (7193). p. 280. 10.1038/453280c.

Lacotte, S., Garcia, A., Decossas, M., Al-Jamal, W.T., Li, S. and Kostarelos, K. (2008) Interfacing functionalized carbon nanohorns with primary phagocytic cells. Advanced Materials, 20 (2). pp. 2421-2426. 10.1002/adma.200702753.

Al-Jamal, W.T., Al-Jamal, K.T., Tian, B., Lacerda, L., Bomans, P.H. and Frederik, P.M. (2008) Lipid-quantum dot bilayer vesicles enhance tumor cell uptake and retention in vitro and in vivo. ACS Nano, 2 (3). pp. 408-418. 10.1021/nn700176a.

Ali-Boucetta, H., Al-Jamal, K.T., McCarthy, D., Prato, M., Bianco, A. and Kostarelos, K. (2008) Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chemical Communications, 12 (1). pp. 459-461. 10.1039/b71235g.

Singh, R., Al-Jamal, K.T., Lacerda, L. and Kostarelos, K. (2008) Nanoengineering artificial lipid envelopes around adenovirus by self-assembly. ACS Nano, 2 (5). pp. 1040-1050. 10.1021/nn8000565.

Emfietzoglou, D., Kostarelos, K., Hadjidoukas, P., Bousis, C., Fotopoulos, A., Pathak, A. and Nikjoo, H. (2008) Subcellular S-factors for low energy electrons: a comparison of Monte Carlo simulations and continuous-slowing-down calculations. International Journal of Radiation Biology, 84 (12). pp. 1034-1044. 10.1080/09553000802460180.

Kostarelos, K. (2008) The long and short of carbon nanotube toxicity. Nature Biotechnology, 26 . pp. 774-776. 10.1038/nbt0708-774.

Lacerda, L., Ali-Boucetta, H., Herrero, M.A., Pastorin, G., Bianco, A., Goins, B. and Kostarelos, K. (2008) Tissue histology and physiology following intravenous administation of different types of functionalized multi-walled carbon nanotubes. Nanomedicine, 3 (2). p. 149. 10.2217/17435889.3.2.149.

Podesta, J.E., Al-Jamal, K.T., Herrero, M.A., Tian, B., Ali-Boucetta, H., Hegde, V., Bianco, A., Prato, M. and Kostarelos, K. (2008) Antitumor activity and prolonged survival by carbon nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. Small, 2 (4). pp. 1176-1185. 10.1002/smll.200801572.

Al-Jamal, W.T., Al-Jamal, K.T. and Kostarelos, K. (2008) Abstract: Liposome-quantum dot hybrids as multimodal therapeutic and imaging agent delivery systems. In: NSTI, 1-5 June 2008, Boston, USA.

Al-Jamal, K.T., Podesta, J.E., Al-Jamal, W.T., Kanthou, C., Akerman, S., Vargesson, N., Tozer, G.M. and Kostarelos, K. (2008) Abstract: Dendrimeric nanocontainers as anti-angiogenic therapeutics. In: 236th ACS National Meeting, 17-21 August 2008, Philadelphia, USA.

Al-Jamal, W.T., Al-Jamal, K.T. and Kostarelos, K. (2008) Abstract: Self-assembled lipid-nanocrystal vesicle hybrids as theranostic devices for cancer. In: 236th ACS National Meeting, 17-21 August 2008, Philadelphia, USA.

Karousis, N., Ali-Boucetta, H., Kostarelos, K. and Tagmatarchis, N. (2008) Aryl-derivatized, water soluble functionaized carbon nanotubes for biomedical applications. Materials Science and Engineering B, 152 (1-3). pp. 8-11. 10.1016/j.mseb.2008.06.002.

Al-Jamal, W.T., Al-Jamal, K.T., Bomans, P.H., Fredericks, P. and Kostarelos, K. (2008) Functionalized-Quantum-Dot–Liposome Hybrids as Multimodal Nanoparticles for Cancer. Small, 4 (9). pp. 1406-1415. 10.1002/smll.200701043.


Singh, J., Pandit, S., Bramwell, V.W. and Alpar, H.O. (2006) Diptheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods, 38 (2). pp. 96-105. 10.1016/j.ymeth.2005.11.003 .

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2006) Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A. Vaccine, 24 (8). pp. 1081-1086. 10.1016/j.vaccine.2005.09.007.

Elvin, S.J., Eyles, J.E., Howard, K.A., Ravichandran, E., Somavarapu, S., Alpar, H.O. and Williamson, E.D. (2006) Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine, 24 . pp. 4433-4439. 10.1016/j.vaccine.2005.12.016.

Bridson, R.H., Santos, R.C.D., Al-Duri, B., McAllister, S.M., Robertson, J. and Alpar, H.O. (2006) The preparation of liposomes using compressed carbon dioxide: strategies, important considerations and comparison with conventional techniques. Journal of Pharmacy and Pharmacology, 58 (6). pp. 775-785. 10.1211/jpp.58.6.0008.

Katas, H. and Alpar, H.O. (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. Journal of Controlled Release, 115 (2). pp. 216-225. 10.1016/j.jconrel.2006.07.021.


Alpar, H.O., Somavarapu, S., Atuah, K.N. and Bramwell, V.W. (2005) Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Advanced Drug Delivery Reviews, 57 (3). pp. 411-430. 10.1016/j.addr.2004.09.004.

Martin, C., Thongborisute, J., Takeuchi, H., Yamamoto, H., Kawashima, Y. and Alpar, H.O. (2005) Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery. International Journal of Pharmaceutics, 298 (2). pp. 339-343. 10.1016/j.ijpharm.2005.03.038 .

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2005) Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine, 23 (16). pp. 1923-1930. 10.1016/j.vaccine.2004.10.016 .

Somavarapu, S., Pandit, S., Gradassi, G., Bandera, M., Ravichandran, E. and Alpar, H.O. (2005) Effect of Vitamin E TPGS on immune response to nasally delivered diphtheria toxoid load poly(caprolactone) microparticles. International Journal of Pharmaceutics, 298 (2). pp. 344-347. 10.1016/j.ijpharm.2005.03.029 .

Murdan, S., Somavarapu, S., Ross, A.C., Alpar, H.O. and Parker, M.C. (2005) Immobilisation of vaccines onto micro-crystals for enhanced thermal stability. International Journal of Pharmaceutics, 296 (1-2). pp. 117-121. 10.1016/j.ijpharm.2005.02.022 .

Papanicolaou, I., Briggs, B. and Alpar, H.O. (2005) Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer. Journal of Drug Targeting, 12 (8). pp. 541-547. 10.1080/10611860400011950.

Hansen, R.K., Zhai, S., Skepper, J.N., Johnston, M.D., Alpar, H.O. and Slater, N.K.H. (2005) Mechanisms of inactivation of HSV-2 during storage in frozen and lyophilised forms. Biotechnology Progress, 21 (3). pp. 911-917. 10.1021/bp049601a.

Martin, C., Somavarapu, S. and Alpar, H.O. (2005) Mucosal delivery of diptheria toxoid using polymer-coated-bioadhesive liposomes as vaccine carriers. Journal of Drug Delivery Science and Technology, 15 (4). pp. 301-306.

Alpar, H.O. and Brey, R.N. (2005) New frontiers in vaccines for emerging pathogens. Advanced Drug Delivery Reviews, 57 (9). pp. 1243-1246. 10.1016/j.addr.2005.01.029.

Bramwell, V.W., Eyles, J.E. and Alpar, H.O. (2005) Particulate delivery systems for biodefense subunit vaccines. Advanced Drug Delivery Reviews, 57 (3). pp. 1247-1265. 10.1016/j.addr.2004.09.009.

Pandit, S., Martin, C. and Alpar, H.O. (2005) Positively charged rifampicin-loaded microspheres for lung delivery. Journal of Drug Delivery Science and Technology, 15 (4). pp. 281-287.

Alpar, H.O., Papanicolaou, I. and Bramwell, V.W. (2005) Strategies for DNA vaccine delivery. Expert Opinion on Drug Delivery, 2 (5). pp. 829-842. 10.1517/17425247.2.5.829.


Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2004) Adjuvant synergy: the effects of nasal coadministration of adjuvants. Immunology and Cell Biology, 82 (6). pp. 628-637. 10.1111/j.0818-9641.2004.01280.x.

Kusonwiriyawong, C., Atuah, K.N., Alpar, H.O., Merkle, H.P. and Walter, E. (2004) Cationic stearylamine-containing biodegradable microparticles for DNA delivery. Journal of Microencapsulation, 21 (1). pp. 25-36. 10.1080/02652040410001653777.

Howard, K.A., Li, X., Somavarapu, S., Singh, J., Green, N., Atuah, K.N., Ozsoy, Y., Seymour, L.W. and Alpar, H.O. (2004) Formulation of microparticle carrier for oral polyplex-based DNA vaccines. Biochimica et Biophysica Acta, 1674 (2). pp. 149-157. 10.1016/j.bbagen.2004.06.009.

Eyles, J.E., Elvin, S.J., Westwood, A., Lebutt, C.S. and Alpar, H.O. (2004) Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine, 22 (31-32). 4365 -4373. 10.1016/j.vaccine.2004.02.049.

Eyles, J.E., Elvin, S.J., Westwood, A., Lebutt, C.S., Alpar, H.O., Somavarapu, S. and Williamson, E.D. (2004) Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine, 22 (31-32). p. 4365. 10.1016/j.vaccine.2004.02.049.

Kohli, A.K. and Alpar, H.O. (2004) Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. International Journal of Pharmaceutics, 275 (1-2). pp. 13-17. 10.1016/j.ijpharm.2003.10.038 .


Bramwell, V.W., Somavarapu, S., Outschoorn, I. and Alpar, H.O. (2003) Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids. Journal of Drug Targeting, 11 (8-10). pp. 525-530. 10.1080/10611860410001683013.

Atuah, K.N., Walter, E., Merkle, H.P. and Alpar, H.O. (2003) Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods. Journal of Microencapsulation, 20 (3). pp. 387-399. 10.1080/10611860410001683013.

Eyles, J.E., Carpenter, Z.C., Alpar, H.O. and Williamson, E.D. (2003) Immunological aspects fo polymer microsphere vaccine delivery systems. Journal of Drug Targeting, 11 . pp. 509-514. 10.1080/10611860410001670017.

Somavarapu, S., Bramwell, V.W. and Alpar, H.O. (2003) Oral plasmid DNA delivery systems for genetic immunisation. Journal of Drug Targeting, 11 (8-10). pp. 547-553. 10.1080/10611860410001683022.

Alpar, H.O. (2003) Strategies for vaccine delivery. Journal of Drug Targeting, 11 (8-10). pp. 459-461. 10.1080/10611860410001683013.

Li, X., Lee, D.K., Chan, A.S. and Alpar, H.O. (2003) Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochimica et Biophysica Acta, 1630 (1). pp. 387-399.

Eyles, J.E., Bramwell, V.W., Singh, J., Williamson, E.D. and Alpar, H.O. (2003) Stimulation of spleen cells in vitro by nanospheric particles containing antigen. Journal of Controlled Release, 86 (1). pp. 25-32. 10.1016/S0168-3659(02)00296-1 .


Alpar, H.O. and Bramwell, V.W. (2002) Current status of DNA vaccines and their route of administration. Critical Reviews in Therapeutic Drug Carrier Systems, 19 (4-5). pp. 307-383. 10.1615/CritRevTherDrugCarrierSyst.v19.i45.

Griffin, K.F., Eyles, J.E., Spiers, I.D., Alpar, H.O. and Williamson, E.D. (2002) Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6. Vaccine, 20 (31-32). pp. 3650-3657. 10.1016/S0264-410X(02)00396-1.

Howard, K.A. and Alpar, H.O. (2002) The development of polyplex-based DNA vaccines. Journal of Drug Targeting, 10 (2). pp. 143-151.

Flick-Smith, H.C., Eyles, J.E., Hebdon, R., Waters, E.L., Beedham, R.J., Stagg, T.J., Miller, J., Alpar, H.O., Baillie, L.W.J. and Williamson, E.D. (2002) Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice. Infection and Immunity, 70 (4). pp. 2022-2028. 10.1128/IAI.70.4.2022-2028.2002.

Bramwell, V.W., Eyles, J.E., Somavarapu, S. and Alpar, H.O. (2002) Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology, 106 (3). pp. 412-418. 10.1046/j.1365-2567.2002.01448.x.


Alpar, H.O., Eyles, J.E., Williamson, E.D. and Somavarapu, S. (2001) Intranasal vaccination against plague, tetanus and diphtheria. Advanced Drug Delivery Reviews, 51 (1-3). pp. 173-201. 10.1016/S0169-409X(01)00166-1 .

Eyles, J.E., Bramwell, V.W., Williamson, E.D. and Alpar, H.O. (2001) Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine, 19 (32). pp. 4732-4742. 10.1016/S0264-410X(01)00220-1.

Eyles, J.E., Spiers, I.D., Williamson, E.D. and Alpar, H.O. (2001) Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. Journal of Pharmacy and Pharmacology, 53 (5). pp. 601-607. 10.1211/0022357011775929.

This list was generated on Fri May 29 03:04:05 2015 BST.